12.03.2021 • NewsIMCD

IMCD sells Nutri Granulations to Huber

IMCD has agreed to sell its Nutri Granulations business to Huber Engineered Materials, a division of J.M. Huber, for an undisclosed sum. The transaction is expected to close by Apr. 1. The Dutch distributor originally acquired the business as part of its takeover of US specialty chemicals distributor E.T. Horn in June 2018.

Huber is an important supplier partner for IMCD, and we are delighted to reach an agreement on the sale of Nutri Granulations,” said Marcus Jordan, IMCD Americas president. “HEM is a favorable long-term fit for Nutri Granulations and this agreement aligns with IMCD’s strategy to focus on the sales, marketing and distribution of specialty chemicals and ingredients.”

Located in La Mirada, California, with 22 employees, Nutri Granulations manufactures food-grade and USP-grade calcium carbonate granulations for the nutraceuticals, food, over-the-counter and pharmaceuticals markets. The company also provides contract blending and granulating services.

Author: Elaine Burridge, Freelance Journalist

IMCD has agreed to sell its Nutri Granulations business to Huber Engineered...
IMCD has agreed to sell its Nutri Granulations business to Huber Engineered Materials. Located in La Mirada, California, Nutri Granulations manufactures food-grade and USP-grade calcium carbonate granulations for the nutraceuticals, food, OTC and pharma markets. (c) Karim Ghantous

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.